Live
- Nazara Technologies sees Q2 profit decline 33 pc to Rs 16 crore
- Jan Aushadhi Kendras become a lifeline for the common man in Jharkhand's Dhanbad
- Rana Daggubati Unveils a Fresh Take on Celebrity Talk Shows with The Rana Daggubati Show
- Pakistan battles smog emergency as millions suffer from respiratory infections
- NASA's AI Earth Copilot: Answer Your Questions About the Planet
- Another tigress released in soft enclosure in Similipal
- Cong, BJP leaders’ rush to join AAP shows we are winning Assembly polls: Kejriwal
- Janajatiya Gaurav Diwas: PM Modi’s selfie with members of Irula tribe draws attention
- Bolivian Opposition leaders arrested on terrorism charges
- 1 in 5 IT decision-makers struggling to find AI/ML talent: Report
Johnson & Johnson Covid vaccine likely in India by July
(Image Source: Reuters)
The Covid-19 vaccine developed by Johnson & Johnson will likely be available in India in small quantities by July this year, sources said.
New Delhi: The Covid-19 vaccine developed by Johnson & Johnson will likely be available in India in small quantities by July this year, sources said.
The Association of Healthcare Providers (India) is in the process of privately procuring the vaccine directly from the US-based manufacturer. Johnson & Johnson's vaccine could arrive in India as early as July, though it will be limited to a few thousand doses initially. The one-shot vaccine will be priced at $25 in India.
The viral vector vaccine does not need to be stored frozen and is suitable for a country like India, which lacks the healthcare infrastructure for storage of vaccines in sub-zero temperatures in tier-2 regions and beyond.
Johnson & Johnson has already initiated talks with the Union government to authenticate its manufacturing process and specifications in the country.
